Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains
Open accessAbstract
We report a comprehensive analysis of sequence features that allow for the production of autonomous human heavy chain variable (V(H)) domains that are stable and soluble in the absence of a light chain partner. Using combinatorial phage-displayed libraries and conventional biophysical methods, we analyzed the entire former light chain interface and the third complementarity determining region (CDR3). Unlike the monomeric variable domains of camelid heavy chain antibodies (V(H)H domains), in which autonomous behavior depends on interactions between the hydrophobic former light chain interface and CDR3, we find that the stability of many in vitro evolved V(H) domains is essentially independent of the CDR3 sequence and instead derives from mutations that increase the hydrophilicity of the former light chain interface by replacing exposed hydrophobic residues with structurally compatible hydrophilic substitutions. The engineered domains can be expressed recombinantly at high yield, are predominantly monomeric at high concentrations, unfold reversibly, and are even more thermostable than typical camelid V(H)H domains. Many of the stabilizing mutations are rare in natural V(H) and V(H)H domains and thus could not be predicted by studying natural sequences and structures. The results demonstrate that autonomous V(H) domains with structural properties beyond the scope of natural frameworks can be derived by using non-natural mutations, which differ from those found in camelid V(H)H d…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
VHH and V-NAR domains contain more hydrophilic residues on the surface that interfaces with VL domains, and some hydrophobic residues analogous to those at the VH/VL interface are used for interacting with hydrophobic residues in the CDR3 loop.
“Compared to the VH domains, the VHH and V-NAR domains contain more hydrophilic residues on the surface that interfaces with the VL domains, and some hydrophobic residues, that are fixed in the sequences, are analogous to those at the VH/VL interface and are used for interacting with hydrophobic residues in the CDR3 loop [11,12].”
From Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments (2020) · cites this paper as [11]
Cited by
Sorted by citations
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304 · see citing works
The CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494 · see citing works
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
Sandomenico, A., Sivaccumar, J. P., & Ruvo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176324 · Cited by 134 · see citing works
“Compared to the VH domains, the VHH and V-NAR domains contain more hydrophilic residues on the surface that interfaces with the VL domains, and some hydrophobic residues, that are fixed in the sequences, are analogous to those at the VH/VL interface and are used for interacting with hydrophobic residues in the CDR3 lo…”
BackgroundFragment-based computational design of antibodies targeting structured epitopes
Aguilar Rangel, M., Bedwell, A., Costanzi, E., Taylor, R. J., Russo, R., Bernardes, G. J. L., Ricagno, S., Frydman, J., Vendruscolo, M., & Sormanni, P. (2022) · Science Advances · doi:10.1126/sciadv.abp9540 · Cited by 55 · see citing works
- Authors
- Barthelemy, P. A., Raab, H., Appleton, B. A., Bond, C. J., Wu, P., Wiesmann, C., & Sidhu, S. S.
- Affiliations
- Genentech (US)
- Corresponding author
- Sidhu, Sachdev S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 283
- Issue
- 6
- Pages
- 3639-3654
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2013128795
- Cited by
- 179
- References
- 0
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 10 · 2023: 4 · 2022: 8 · 2021: 11 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 14 · 2016: 8 · 2015: 12 · 2014: 14 · 2013: 16 · 2012: 20
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- CDR3, protein stability, protein solubility, hydrophobic residues, thermal stability, phage display
- MeSH terms
- Alanine, Amino Acid Sequence, Base Sequence, Biophysics, Humans, Immunoglobulin Heavy Chains, Molecular Conformation, Molecular Sequence Data, Protein Conformation, Recombinant Proteins, Protein Engineering, Protein Structure, Tertiary, Crystallography, X-Ray, Peptide Library, Complementarity Determining Regions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review